Share

A Prospective, Non-Interventional, Observational, Multicenter Study to Investigate Dosage, Effectiveness, and Safety of Perampanel when Used as First Adjunctive Therapy in the Routine Clinical Care of Subjects ≥12 Years with Partial Onset Seizures With or Without Secondary Generalization or with Primary Generalized Tonic–Clonic Seizures Associated with Idiopathic Generalized Epilepsy. Study E2007-M044-512

Project objectives

The project has the general objective of evaluating the efficacy and safety of Perampanel in patients suffering from epilepsy

Project Manager

Dr. Giovanni Assenza - Principal Investigator

Other Institutions involved

  • Multicenter study
QUICK LINKS
magnifiercrossmenuchevron-downchevron-leftchevron-right